SubHero Banner

COVID-19 Vaccines – FDA Advisors Discuss Vaccine Boosters

September 17, 2021 - The Food and Drug Administration convened a Vaccine and Biologic Products Advisory Committee (VRBPAC) to discuss expanding the indication for Pfizer’s COVID-19 vaccine Comirnaty®. Pfizer is seeking FDA approval of a 3rd dose of Comirnaty administered 6 months after the initial 2-dose series, in individuals ages 16 years and above.

Download PDF